Evoke Pharma, Inc. (EVOK): $1.09

-0.05 (-4.39%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Evoke Pharma Inc (EVOK) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering EVOK.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2 $10 $9 $9.5 $1.08 779.63%

EVOK Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EVOK as an investment opportunity.

  • Evoke Pharma Inc's upside potential (average analyst target price relative to current price) is greater than 98.33% of all US stocks.
  • The number of analysts covering the stock of EVOK is greater than 13.8% of Healthcare stocks.
  • EVOK has a less variance in analysts' estimates than 83.02% of Pharmaceutical Products stocks.
  • EVOK has a higher average analyst price target than 18% of all US stocks.

Is EVOK a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6823 seconds.